摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

栝楼仁二醇 | 118117-31-0

中文名称
栝楼仁二醇
中文别名
栝楼萜二醇
英文名称
karounidiol
英文别名
(3R,4aR,6aS,6bS,8aS,11R,12aR,14bS)-11-(hydroxymethyl)-4,4,6a,6b,8a,11,14b-heptamethyl-1,2,3,4a,5,7,8,9,10,12,12a,13-dodecahydropicen-3-ol
栝楼仁二醇化学式
CAS
118117-31-0
化学式
C30H48O2
mdl
——
分子量
440.71
InChiKey
UIXJVDGAGQPTFR-ZSBHZPGCSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    溶于氯仿、二氯甲烷、乙酸乙酯、DMSO、丙酮等。

计算性质

  • 辛醇/水分配系数(LogP):
    7
  • 重原子数:
    32
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    栝楼仁二醇氢氧化钾 、 chromium trioxide-pyridine complex 作用下, 以 吡啶甲醇 为溶剂, 反应 6.0h, 生成 3α-hydroxymultiflora-7,9(11)-dien-29α-oic acid
    参考文献:
    名称:
    Akihisa, Toshihiro; Tamura, Toshitake; Matsumoro, Taro, Journal of the Chemical Society. Perkin transactions I, 1988, p. 439 - 444
    摘要:
    DOI:
  • 作为产物:
    描述:
    (3α,7β)-3,7,29-trihydroxymultiflor-8-ene-3,29-diyl dibenzoate 在 氢氧化钾 作用下, 以 甲醇 为溶剂, 反应 2.0h, 生成 栝楼仁二醇
    参考文献:
    名称:
    Trichosanthes kirilowi​​i种子中的三萜三萜酯
    摘要:
    两个新的三萜multiflorane酯,(3 α,7 β)-3,7,29-trihydroxymultiflor -8-烯3,29二基二苯甲酸酯(2)和(3 α)-3,29二羟基-7- oxomultiflor -8-烯3,29二基二苯甲酸酯(3)已经从氯仿中分离3的种子的提取物栝楼有两个公知的化合物,(3,一起α,5 α,22 ë)-24-ethylcholesta- 7,22,25(27)-三烯-3-醇和金刚烷醇。新化合物的结构进行了阐明的广泛NMR实验的基础上,并通过一个X射线晶体学分析的装置2。初步的细胞毒性试验表明2和3基本上对K562细胞系无活性。
    DOI:
    10.1002/hlca.200590202
点击查看最新优质反应信息

文献信息

  • Five D: C-Friedo-Oleanane Triterpenes from the Seeds of Trichosanthes kirilowii MAXIM. and Their Anti-inflammatory Effects.
    作者:Toshihiro AKIHISA、Ken YASUKAWA、Yumiko KIMURA、Michio TAKIDO、Wilhelmus C. M. C. KOKKE、Toshitake TAMURA
    DOI:10.1248/cpb.42.1101
    日期:——
    Five triterpenes with a D : C-friedo-oleanane skeleton, D : C-friedo-oleana-7, 9(11)-diene-3β, 29-diol (3-epikarounidiol), 7-oxo-D : C-friedo-olean-8-en-3β-ol (7-oxoisomultiflorenol), 7-oxo-8β-D : C-friedo-olean-9(11)-ene-3α, 29-diol, D : C-friedo-olean-8-ene-3α, 29-diol (3-epibryonolol), and D : C-friedo-olean-8-ene-3β, 29-diol (bryonolol), the first four of which are new naturally occurring compounds, were isolated from the seeds of Trichosanthes kirilowii MAXIM. The structures were determined by spectral and chemical methods. 3-Epikarounidiol, 7-oxoisomultiflorenol, and 3-epibryonolol showed marked inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear inflammation in mice. The 50% inhibitory dose of these triterpenes for TPA-induced inflammation (1 μg) was 0.2-0.6 mg/ear.
    从Trichosanthes kirilowii MAXIM的种子中分离出五种具有D:C-friedo-oleanane骨架的三萜类化合物,即D:C-friedo-oleana-7,9(11)-diene-3β,29-diol(3-epikarounidiol)、7-oxo-D:C-friedo-olean-8-en-3β-ol(7-oxoisomultiflorenol)、7-oxo-8β-D:C-friedo-olean-9(11)-ene-3α,29-diol、D:C-friedo-olean-8-ene-3α,29-diol(3-epibryonolol)和D:C-friedo-olean-8-ene-3β,29-diol(bryonolol),其中前四种是新发现的天然化合物。通过光谱和化学方法确定了这些化合物的结构。3-Epikarounidiol、7-oxoisomultiflorenol和3-epibryonolol对小鼠12-O-tetradecanoylphorbol-13-acetate(TPA)诱导的耳部炎症具有显著的抑制活性。这些三萜类化合物对TPA诱导的炎症的5
  • PROPHYLACTIC AGENT AND/OR THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASE
    申请人:Green Tech Co., Ltd.
    公开号:EP3881898A1
    公开(公告)日:2021-09-22
    The problems to be solved by the present invention are to provide a novel agent for preventing and/or treating a neurodegenerative disease, and a pharmaceutical composition comprising the agent for preventing and/or treating a neurodegenerative disease. The problems are solved by providing an agent for preventing and/or treating a neurodegenerative disease, the agent comprising as an active ingredient an extract of Momordica charantia var. pavel, and preferably the agent is for use in treatment or prevention of a disease selected from Alzheimer's disease, Parkinson's disease, Down syndrome, tauopathy (for example, argyrophilic grain dementia, senile dementia of neurofibrillary tangle type, progressive supranuclear palsy, degeneration of cerebral cortex or Pick disease), and dementia with lewy bodies.
    本发明要解决的问题是提供一种预防和/或治疗神经退行性疾病的新型制剂,以及一种包含该制剂的预防和/或治疗神经退行性疾病的药物组合物。解决上述问题的方法是提供一种用于预防和/或治疗神经退行性疾病的制剂,该制剂的活性成分包括 Momordica charantia var.优选地,该制剂用于治疗或预防选自阿尔茨海默病、帕金森病、唐氏综合征、陶氏病(例如霰粒肿性痴呆、神经纤维缠结型老年痴呆、进行性核上性麻痹、大脑皮层变性或皮克病)和白细胞增多性痴呆的疾病。
  • AGENT FOR PREVENTING AND/OR TREATING NEURODEGENERATIVE DISEASES
    申请人:GREEN TECH CO., LTD.
    公开号:US20220031787A1
    公开(公告)日:2022-02-03
    The problems to be solved by the present invention are to provide a novel agent for preventing and/or treating a neurodegenerative disease, and a pharmaceutical composition comprising the agent for preventing and/or treating a neurodegenerative disease. The problems are solved by providing an agent for preventing and/or treating a neurodegenerative disease, the agent comprising as an active ingredient an extract of Momordica charantia var. pavel, and preferably the agent is for use in treatment or prevention of a disease selected from Alzheimer's disease, Parkinson's disease, Down syndrome, tauopathy (for example, argyrophilic grain dementia, senile dementia of neurofibrillary tangle type, progressive supranuclear palsy, degeneration of cerebral cortex or Pick disease), and dementia with lewy bodies.
  • Akihisa, Toshihiro; Tamura, Toshitake; Matsumoro, Taro, Journal of the Chemical Society. Perkin transactions I, 1988, p. 439 - 444
    作者:Akihisa, Toshihiro、Tamura, Toshitake、Matsumoro, Taro、Eggleston, Drake S.、Kokke, W.C.M.C.、Shimizu, Naoto
    DOI:——
    日期:——
  • Multiflorane Triterpene Esters from the Seeds ofTrichosanthes kirilowii
    作者:Tao Wu、Xue-Mei Cheng、S. W. Annie Bligh、Gui-Xin Chou、Zheng-Tao Wang、Alan Bashall、Chris Branford-White
    DOI:10.1002/hlca.200590202
    日期:2005.10
    Two new multiflorane triterpene esters, (3α,7β)-3,7,29-trihydroxymultiflor-8-ene-3,29-diyl dibenzoate (2) and (3α)-3,29-dihydroxy-7-oxomultiflor-8-ene-3,29-diyl dibenzoate (3) have been isolated from the CHCl3 extract of the seeds of Trichosanthes kirilowii, together with two known compounds, (3α,5α,22E)-24-ethylcholesta-7,22,25(27)-trien-3-ol and darutigenol. The structures of the new compounds were
    两个新的三萜multiflorane酯,(3 α,7 β)-3,7,29-trihydroxymultiflor -8-烯3,29二基二苯甲酸酯(2)和(3 α)-3,29二羟基-7- oxomultiflor -8-烯3,29二基二苯甲酸酯(3)已经从氯仿中分离3的种子的提取物栝楼有两个公知的化合物,(3,一起α,5 α,22 ë)-24-ethylcholesta- 7,22,25(27)-三烯-3-醇和金刚烷醇。新化合物的结构进行了阐明的广泛NMR实验的基础上,并通过一个X射线晶体学分析的装置2。初步的细胞毒性试验表明2和3基本上对K562细胞系无活性。
查看更多

同类化合物

(5β,6α,8α,10α,13α)-6-羟基-15-氧代黄-9(11),16-二烯-18-油酸 (3S,3aR,8aR)-3,8a-二羟基-5-异丙基-3,8-二甲基-2,3,3a,4,5,8a-六氢-1H-天青-6-酮 (2Z)-2-(羟甲基)丁-2-烯酸乙酯 (2S,4aR,6aR,7R,9S,10aS,10bR)-甲基9-(苯甲酰氧基)-2-(呋喃-3-基)-十二烷基-6a,10b-二甲基-4,10-dioxo-1H-苯并[f]异亚甲基-7-羧酸盐 (+)顺式,反式-脱落酸-d6 龙舌兰皂苷乙酯 龙脑香醇酮 龙脑烯醛 龙脑7-O-[Β-D-呋喃芹菜糖基-(1→6)]-Β-D-吡喃葡萄糖苷 龙牙楤木皂甙VII 龙吉甙元 齿孔醇 齐墩果醛 齐墩果酸苄酯 齐墩果酸甲酯 齐墩果酸乙酯 齐墩果酸3-O-alpha-L-吡喃鼠李糖基(1-3)-beta-D-吡喃木糖基(1-3)-alpha-L-吡喃鼠李糖基(1-2)-alpha-L-阿拉伯糖吡喃糖苷 齐墩果酸 beta-D-葡萄糖酯 齐墩果酸 beta-D-吡喃葡萄糖基酯 齐墩果酸 3-乙酸酯 齐墩果酸 3-O-beta-D-葡吡喃糖基 (1→2)-alpha-L-吡喃阿拉伯糖苷 齐墩果酸 齐墩果-12-烯-3b,6b-二醇 齐墩果-12-烯-3,24-二醇 齐墩果-12-烯-3,21,23-三醇,(3b,4b,21a)-(9CI) 齐墩果-12-烯-3,11-二酮 齐墩果-12-烯-2α,3β,28-三醇 齐墩果-12-烯-29-酸,3,22-二羟基-11-羰基-,g-内酯,(3b,20b,22b)- 齐墩果-12-烯-28-酸,3-[(6-脱氧-4-O-b-D-吡喃木糖基-a-L-吡喃鼠李糖基)氧代]-,(3b)-(9CI) 鼠特灵 鼠尾草酸醌 鼠尾草酸 鼠尾草酚酮 鼠尾草苦内脂 黑蚁素 黑蔓醇酯B 黑蔓醇酯A 黑蔓酮酯D 黑海常春藤皂苷A1 黑檀醇 黑果茜草萜 B 黑五味子酸 黏黴酮 黏帚霉酸 黄黄质 黄钟花醌 黄质醛 黄褐毛忍冬皂苷A 黄蝉花素 黄蝉花定